Lupin’s arm lists NHI drug price for Bipresso extended release tablets

30 Aug 2017 Evaluate

Lupin’s Japanese subsidiary Kyowa Pharmaceutical Industry Co., has listed the NHI (National Health Insurance) drug price for Bipresso (generic name: Quetiapine Fumarate) extended release 50mg and 150 mg tablets for the treatment of depressive symptoms associated with bipolar disorder. NHI drug price are listed at 71.00 Yen per 50mg tablet and 188.60 Yen per 150mg tablet.

Astellas Pharma Inc. obtained approval for Bipresso Extended Release Tablets on July 3, 2017. Bipresso Extended Release Tablets contains the active ingredient quetiapine fumarate and is an extended-release tablet to be taken orally once a day. Based on the agreement between Astellas and Kyowa made in February 2017, Kyowa will distribute, sell and promote Bipresso Extended-Release Tablets exclusively in Japan.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2089.65 -0.50 (-0.02%)
16-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1782.80
Dr. Reddys Lab 1279.00
Cipla 1500.00
Zydus Lifesciences 913.90
Lupin 2089.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×